Genetron Health to Participate in the Credit Suisse Asian Investment Conference
March 21, 2022 08:00 ET
|
Genetron Holdings Limited
BEIJING, March 21, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Announce Fourth Quarter and Full Year 2021 Unaudited Financial Results and Host Investor Call on March 29, 2022
March 09, 2022 16:05 ET
|
Genetron Holdings Limited
BEIJING, March 09, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Companion Diagnostic Collaboration Agreement with HUTCHMED’s ORPATHYS® for NSCLC
February 10, 2022 03:06 ET
|
Genetron Holdings Limited
BEIJING, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Participate in Upcoming Investor Conferences
January 31, 2022 08:00 ET
|
Genetron Holdings Limited
BEIJING, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reiterates Full Year 2021 Revenue Guidance
January 10, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health’s Social Contribution Campaign to Make Precision Medicine More Accessible
December 13, 2021 01:30 ET
|
Genetron Holdings Limited
BEIJING, Dec. 13, 2021 (GLOBE NEWSWIRE) -- (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling...
Genetron Health Reports Third Quarter 2021 Unaudited Financial Results
November 30, 2021 05:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China
November 29, 2021 22:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reveals Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual Meeting
November 16, 2021 05:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Participate in the 8th BioCentury-BayHelix China Healthcare Summit
November 15, 2021 08:00 ET
|
Genetron Holdings Limited
BEIJING, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...